Skip to main content
Top
Published in: BMC Public Health 1/2020

Open Access 01-12-2020 | Care | Research article

CKDNET, a quality improvement project for prevention and reduction of chronic kidney disease in the Northeast Thailand

Authors: Ubon Cha’on, Kanok Wongtrangan, Bandit Thinkhamrop, Sajja Tatiyanupanwong, Chulaporn Limwattananon, Cholatip Pongskul, Thanachai Panaput, Chalongchai Chalermwat, Worachart Lert-itthiporn, Amod Sharma, Sirirat Anutrakulchai, CKDNET group

Published in: BMC Public Health | Issue 1/2020

Login to get access

Abstract

Background

The incidence of chronic kidney disease (CKD) is high in the Northeast Thailand compared to other parts of the country. Therefore, a broad program applying all levels of care is inevitable. This paper describes the results of the first year trial of the Chronic Kidney Disease Prevention in the Northeast Thailand (CKDNET), a quality improvement project collaboratively established to curb CKD.

Methods

We have covered general population, high risk persons and all stages of CKD patients with expansive strategies such as early screening, effective CKD registry, prevention and CKD comprehensive care models including cost effectiveness analysis.

Results

The preliminary results from CKD screening in general population of two rural sub-districts show that 26.8% of the screened population has CKD and 28.9% of CKD patients are of unknown etiology. We have established the CKD registry that has enlisted a total of 10.4 million individuals till date, of which 0.13 million are confirmed to have CKD. Pamphlets, posters, brochures and other media of 94 different types in the total number of 478,450 has been distributed for CKD education and awareness at the community level. A CKD guideline that suits for local situation has been formulated to deal the problem effectively and improve care. Moreover, our multidisciplinary intervention and self-management supports were effective in improving glomerular filtration rate (49.57 versus 46.23 ml/min/1.73 m2; p < 0.05), blood pressure (129.6/76.1 versus 135.8/83.6 mmHg) and quality of life of CKD patients included in the program compared to those of the patients under conventional care. The cost effectiveness analysis revealed that lifetime cost for the comprehensive health services under the CKDNET program was 486,898 Baht compared to that of the usual care of 479,386 Baht, resulting in an incremental-cost effectiveness ratio of 18,702 Baht per quality-adjusted life years gained.

Conclusion

CKDNET, a quality improvement project of the holistic approach is currently applying to the population in the Northeast Thailand which will facilitate curtailing of CKD burden in the region.
Appendix
Available only for authorised users
Literature
1.
go back to reference GBD. 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544.CrossRef GBD. 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544.CrossRef
2.
go back to reference Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765.CrossRef Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765.CrossRef
3.
go back to reference Whaley-Connell A, Shlipak MG, Inker LA, Kurella Tamura M, Bomback AS, Saab G, et al. Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med. 2012;125(7):661–9.CrossRef Whaley-Connell A, Shlipak MG, Inker LA, Kurella Tamura M, Bomback AS, Saab G, et al. Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med. 2012;125(7):661–9.CrossRef
4.
go back to reference Rao KSS, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829–41.CrossRef Rao KSS, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829–41.CrossRef
5.
go back to reference Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.CrossRef Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.CrossRef
6.
go back to reference Jayatilake N, Mendis S, Maheepala P, Mehta FR. Chronic kidney disease of uncertain aetiology: prevalence and causative factors in a developing country. BMC Nephrol. 2013;14(1):180.CrossRef Jayatilake N, Mendis S, Maheepala P, Mehta FR. Chronic kidney disease of uncertain aetiology: prevalence and causative factors in a developing country. BMC Nephrol. 2013;14(1):180.CrossRef
7.
go back to reference Tatapudi RR, Rentala S, Gullipalli P, Komarraju AL, Singh AK, Tatapudi VS, et al. High prevalence of CKD of unknown etiology in Uddanam, India. Kidney Int Rep. 2019;4(3):380–9.CrossRef Tatapudi RR, Rentala S, Gullipalli P, Komarraju AL, Singh AK, Tatapudi VS, et al. High prevalence of CKD of unknown etiology in Uddanam, India. Kidney Int Rep. 2019;4(3):380–9.CrossRef
8.
go back to reference Torres C, Aragon A, Gonzalez M, Lopez I, Jakobsson K, Elinder CG, et al. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am J Kidney Dis. 2010;55(3):485–96.CrossRef Torres C, Aragon A, Gonzalez M, Lopez I, Jakobsson K, Elinder CG, et al. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am J Kidney Dis. 2010;55(3):485–96.CrossRef
9.
go back to reference Ingsathit A, Thakkinstian A, Chaiprasert A, Sangthawan P, Gojaseni P, Kiattisunthorn K, et al. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant. 2010;25(5):1567–75.CrossRef Ingsathit A, Thakkinstian A, Chaiprasert A, Sangthawan P, Gojaseni P, Kiattisunthorn K, et al. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant. 2010;25(5):1567–75.CrossRef
10.
go back to reference Ong-Ajyooth L, Vareesangthip K, Khonputsa P, Aekplakorn W. Prevalence of chronic kidney disease in Thai adults: a national health survey. BMC Nephrol. 2009;10:35.CrossRef Ong-Ajyooth L, Vareesangthip K, Khonputsa P, Aekplakorn W. Prevalence of chronic kidney disease in Thai adults: a national health survey. BMC Nephrol. 2009;10:35.CrossRef
11.
go back to reference Yanagawa M, Kawamura J, Onishi T, Soga N, Kameda K, Sriboonlue P, et al. Incidence of urolithiasis in Northeast Thailand. Int J Urol. 1997;4(6):537–40.CrossRef Yanagawa M, Kawamura J, Onishi T, Soga N, Kameda K, Sriboonlue P, et al. Incidence of urolithiasis in Northeast Thailand. Int J Urol. 1997;4(6):537–40.CrossRef
12.
go back to reference Hemmelgarn BR, Zhang J, Manns BJ, James MT, Quinn RR, Ravani P, et al. Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA. 2010;303(12):1151–8.CrossRef Hemmelgarn BR, Zhang J, Manns BJ, James MT, Quinn RR, Ravani P, et al. Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA. 2010;303(12):1151–8.CrossRef
13.
go back to reference Plantinga LC, Boulware LE, Coresh J, Stevens LA, Miller ER, Saran R, et al. Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med. 2008;168(20):2268–75.CrossRef Plantinga LC, Boulware LE, Coresh J, Stevens LA, Miller ER, Saran R, et al. Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med. 2008;168(20):2268–75.CrossRef
15.
go back to reference Barrett BJ, Garg AX, Goeree R, Levin A, Molzahn A, Rigatto C, et al. A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial. Clin J Am Soc Nephrol. 2011;6(6):1241–7.CrossRef Barrett BJ, Garg AX, Goeree R, Levin A, Molzahn A, Rigatto C, et al. A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial. Clin J Am Soc Nephrol. 2011;6(6):1241–7.CrossRef
16.
go back to reference Devins GM, Mendelssohn DC, Barre PE, Binik YM. Predialysis psychoeducational intervention and coping styles influence time to dialysis in chronic kidney disease. Am J Kidney Dis. 2003;42(4):693–703.CrossRef Devins GM, Mendelssohn DC, Barre PE, Binik YM. Predialysis psychoeducational intervention and coping styles influence time to dialysis in chronic kidney disease. Am J Kidney Dis. 2003;42(4):693–703.CrossRef
17.
go back to reference Saran R, Hedgeman E, Plantinga L, Burrows NR, Gillespie BW, Young EW, et al. Establishing a national chronic kidney disease surveillance system for the United States. Clin J Am Soc Nephrol. 2010;5(1):152–61.CrossRef Saran R, Hedgeman E, Plantinga L, Burrows NR, Gillespie BW, Young EW, et al. Establishing a national chronic kidney disease surveillance system for the United States. Clin J Am Soc Nephrol. 2010;5(1):152–61.CrossRef
18.
go back to reference Trivedi HS, Pang MM, Campbell A, Saab P. Slowing the progression of chronic renal failure: economic benefits and patients’ perspectives. Am J Kidney Dis. 2002;39(4):721–9.CrossRef Trivedi HS, Pang MM, Campbell A, Saab P. Slowing the progression of chronic renal failure: economic benefits and patients’ perspectives. Am J Kidney Dis. 2002;39(4):721–9.CrossRef
19.
go back to reference KDIGO CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3:1–150.CrossRef KDIGO CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3:1–150.CrossRef
21.
go back to reference Brown WW, Peters RM, Ohmit SE, Keane WF, Collins A, Chen SC, et al. Early detection of kidney disease in community settings: the kidney early evaluation program (KEEP). Am J Kidney Dis. 2003;42(1):22–35.CrossRef Brown WW, Peters RM, Ohmit SE, Keane WF, Collins A, Chen SC, et al. Early detection of kidney disease in community settings: the kidney early evaluation program (KEEP). Am J Kidney Dis. 2003;42(1):22–35.CrossRef
22.
23.
go back to reference Venuthurupalli SK, Hoy WE, Healy HG, Salisbury A, Fassett RG, CKD. QLD: chronic kidney disease surveillance and research in Queensland, Australia. Nephrol Dial Transplant. 2012;27(Suppl 3):139–45.CrossRef Venuthurupalli SK, Hoy WE, Healy HG, Salisbury A, Fassett RG, CKD. QLD: chronic kidney disease surveillance and research in Queensland, Australia. Nephrol Dial Transplant. 2012;27(Suppl 3):139–45.CrossRef
24.
go back to reference Sobrinho A, da Silva LD, Perkusich A, Pinheiro ME, Cunha P. Design and evaluation of a mobile application to assist the self-monitoring of the chronic kidney disease in developing countries. BMC Med Inform Decis Mak. 2018;18(1):7.CrossRef Sobrinho A, da Silva LD, Perkusich A, Pinheiro ME, Cunha P. Design and evaluation of a mobile application to assist the self-monitoring of the chronic kidney disease in developing countries. BMC Med Inform Decis Mak. 2018;18(1):7.CrossRef
25.
go back to reference Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG, et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med. 2001;135(12):1019–28.CrossRef Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG, et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med. 2001;135(12):1019–28.CrossRef
26.
go back to reference Fox CH, Voleti V, Khan LS, Murray B, Vassalotti J. A quick guide to evidence-based chronic kidney disease care for the primary care physician. Postgrad Med. 2008;120(2):1–6.CrossRef Fox CH, Voleti V, Khan LS, Murray B, Vassalotti J. A quick guide to evidence-based chronic kidney disease care for the primary care physician. Postgrad Med. 2008;120(2):1–6.CrossRef
28.
go back to reference Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S. Applied methods of cost-effectiveness analysis in healthcare. 1st ed. Oxford: Oxford University Press; 2011. Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S. Applied methods of cost-effectiveness analysis in healthcare. 1st ed. Oxford: Oxford University Press; 2011.
Metadata
Title
CKDNET, a quality improvement project for prevention and reduction of chronic kidney disease in the Northeast Thailand
Authors
Ubon Cha’on
Kanok Wongtrangan
Bandit Thinkhamrop
Sajja Tatiyanupanwong
Chulaporn Limwattananon
Cholatip Pongskul
Thanachai Panaput
Chalongchai Chalermwat
Worachart Lert-itthiporn
Amod Sharma
Sirirat Anutrakulchai
CKDNET group
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2020
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-020-09387-w

Other articles of this Issue 1/2020

BMC Public Health 1/2020 Go to the issue